Crispr-Cas9-Mediated Pre-Transcriptional Silencing of Mutant Atxn3 Decreases Motor Impairments of an In Vivo Machado-Joseph Disease Model

AuthID
P-00Q-G28
7
Author(s)
Matos, C
·
Pena, F
·
Conceicao, A
·
Lopes, S
·
Duarte, S
·
de Almeida, LP
Tipo de Documento
Abstract
Year published
2019
Publicado
in MOLECULAR THERAPY, ISSN: 1525-0016
Volume: 27, Número: 4, Páginas: 120-121 (2)
Conference
22Nd Annual Meeting of the American-Society-Of-Gene-And-Cell-Therapy (Asgct), Date: APR 29-MAY 02, 2019, Location: Washington, DC, Patrocinadores: Amer Soc Gene & Cell Therapy
Indexing
Publication Identifiers
Wos: WOS:000464381001094
Source Identifiers
ISSN: 1525-0016
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.